. . "??? Price +1.5%, volume +4.0%, currency +7.1%, portfolio -0.2%??? At Pharmaceuticals, growth was achieved mainly in North America and in the emerging markets, especially China.??? Kogenate developed positively, with growth driven by increased shipments to our distribution partner during this quarter and by higher volumes resulting from tender businesses in Australia.??? Global sales of Betaferon r" . .